US Stock MarketDetailed Quotes

CANF Can-Fite BioPharma

Watchlist
  • 4.5000
  • +0.6000+15.38%
Close Jul 19 16:00 ET
  • 4.5100
  • +0.0100+0.22%
Post 19:26 ET
22.46MMarket Cap-1500P/E (TTM)

Can-Fite BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Can-Fite BioPharma Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

155.00K

-21.32%
EPS(YoY)

-1.52

0.00%
Analyst Rating

Buy

May 9, 2024

Can-Fite BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 150.000K--
--2024/Q1-- / 150.000K--
--2023/Q4155.000K / 200.000K--
--2023/Q3196.000K / 200.000K--
--2023/Q2196.000K / 200.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 150.000K--
--2024/Q1-- / 150.000K--
--2023/Q4155.000K / 200.000K--
--2023/Q3196.000K / 200.000K--
--2023/Q2196.000K / 200.000K--

Unlock Free Earnings Estimates

Can-Fite BioPharma Earnings Reports

  • Can-Fite BioPharma | 6-K/A: Report of foreign private issuer (related to financial reporting)

    Jun 7 16:20 ET

  • Can-Fite BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)

    May 22 16:20 ET

  • Can-Fite BioPharma | 20-F: Registration statement / Annual report / Transition report

    Mar 28 09:34 ET

  • Can-Fite BioPharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 28 07:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 9, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-1.47%